Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2011, Article ID 159619, 8 pages
http://dx.doi.org/10.1155/2011/159619
Research Article

Metals and Breast Cancer: Risk Factors or Healing Agents?

1Department of Neuropathology, Heinrich-Heine University, 40225 Düsseldorf, Germany
2Weill Cornell Medical College in Qatar, Qatar Foundation, Education City, P.O. Box 24144, Doha, Qatar

Received 21 April 2011; Accepted 24 May 2011

Academic Editor: David O. Carpenter

Copyright © 2011 Ana-Maria Florea and Dietrich Büsselberg. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. S. WHO, 2011, http://www.who.int/mediacentre/factsheets/fs297/en/index.html.
  2. C. M. Gallagher, J. J. Chen, and J. S. Kovach, “Environmental cadmium and breast cancer risk,” Aging, vol. 2, no. 11, pp. 804–814, 2010. View at Google Scholar
  3. R. Y. Wood and N. R. Della-Monica, “Psychosocial factors influencing breast cancer risk appraisal among older women,” Qualitative Health Research, vol. 21, no. 6, pp. 783–795, 2011. View at Publisher · View at Google Scholar · View at PubMed
  4. M. Jevtic, R. Velicki, M. Popovic, N. Cemerlic-Adjic, S. S. Babovic, and L. Velicki, “Dietary influence on breast cancer,” Journal of B.U.ON., vol. 15, no. 3, pp. 455–461, 2010. View at Google Scholar · View at Scopus
  5. M. Salhab, S. Bismohun, and K. Mokbel, “Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery,” BMC Women's Health, vol. 10, article 28, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. L. Atkinson, M. Zhang, P. Diagaradjane et al., “Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy,” Science Translational Medicine, vol. 2, no. 55, Article ID 55ra79, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. V. Okoh, A. Deoraj, and D. Roy, “Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer,” Biochimica et Biophysica Acta, vol. 1815, no. 1, pp. 115–133, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. C. L. Siewit, B. Gengler, E. Vegas, R. Puckett, and M. C. Louie, “Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERα and c-Jun,” Molecular Endocrinology, vol. 24, no. 5, pp. 981–992, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. A. McElroy, M. M. Shafer, A. Trentham-Dietz, J. M. Hampton, and P. A. Newcomb, “Cadmium exposure and breast cancer risk,” Journal of the National Cancer Institute, vol. 98, no. 12, pp. 869–873, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. L. Benbrahim-Tallaa, E. J. Tokar, B. A. Diwan, A. L. Dill, J. F. Coppin, and M. P. Waalkes, “Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype,” Environmental Health Perspectives, vol. 117, no. 12, pp. 1847–1852, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A.-M. Florea and D. Büsselberg, “Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects,” Cancers, vol. 3, no. 1, pp. 1351–1371, 2011. View at Publisher · View at Google Scholar
  12. S. A. N. Silvera and T. E. Rohan, “Trace elements and cancer risk: a review of the epidemiologic evidence,” Cancer Causes and Control, vol. 18, no. 1, pp. 7–27, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. M. Florea and D. Büsselberg, “Occurrence, use and potential toxic effects of metals and metal compounds,” BioMetals, vol. 19, no. 4, pp. 419–427, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. G. N. Schrauzer, “Interactive effects of selenium and cadmium on mammary tumor development and growth in MMTV-Infected female mice. A model study on the roles of cadmium and selenium in human breast cancer,” Biological Trace Element Research, vol. 123, no. 1–3, pp. 27–34, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. Y. Choe, S. J. Kim, H. G. Kim et al., “Evaluation of estrogenicity of major heavy metals,” Science of the Total Environment, vol. 312, no. 1–3, pp. 15–21, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. F. Saleh, A. Behbehani, S. Asfar, I. Khan, and G. Ibrahim, “Abnormal blood levels of trace elements and metals, DNA damage, and breast cancer in the state of Kuwait,” Biological Trace Element Research, pp. 1–14, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. Y. Cui, S. Vogt, N. Olson, A. G. Glass, and T. E. Rohan, “Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 8, pp. 1682–1685, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. Ying, K. Myers, S. Bottomley, T. Helleday, and H. E. Bryant, “BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells,” Nucleic Acids Research, vol. 37, no. 15, pp. 5105–5113, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. A. M. Florea and D. Büsselberg, “Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells,” Toxicology Letters, vol. 179, no. 1, pp. 34–42, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. M. Florea, F. Splettstoesser, and D. Büsselberg, “Arsenic trioxide (As2O3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK),” Toxicology and Applied Pharmacology, vol. 220, no. 3, pp. 292–301, 2007. View at Google Scholar
  21. R. Ruiz-Ramos, L. Lopez-Carrillo, A. D. Rios-Perez, A. De Vizcaya-Ruíz, and M. E. Cebrian, “Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-κB activation and cell proliferation in human breast cancer MCF-7 cells,” Mutation Research, vol. 674, no. 1-2, pp. 109–115, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. Ruiz-Ramos, L. López-Carrillo, A. Albores, R. U. Hernández-Ramírez, and M. E. Cebrian, “Sodium arsenite alters cell cycle and MTHFR, MT1/2, and c-Myc protein levels in MCF-7 cells,” Toxicology and Applied Pharmacology, vol. 241, no. 3, pp. 269–274, 2009. View at Publisher · View at Google Scholar · View at PubMed
  23. Y. Liu, J. M. Hock, C. Sullivan et al., “Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation,” Journal of Cellular Biochemistry, vol. 111, no. 6, pp. 1546–1555, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. X. Wang, P. Gao, M. Long et al., “Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide,” Medical Oncology. In press. View at Publisher · View at Google Scholar · View at PubMed
  25. R. W. Ahn, F. Chen, H. Chen et al., “A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer,” Clinical Cancer Research, vol. 16, no. 14, pp. 3607–3617, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. T. Wang, S. Zhang, M. Zeng et al., “Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer,” Medical Oncology. In press. View at Publisher · View at Google Scholar · View at PubMed
  27. S. Pacini, T. Punzi, G. Morucci, M. Gulisano, and M. Ruggiero, “A paradox of cadmium: a carcinogen that impairs the capability of human breast cancer cells to induce angiogenesis,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 28, no. 1, pp. 85–88, 2009. View at Google Scholar
  28. X. Yu, E. J. Filardo, and Z. A. Shaikh, “The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells,” Toxicology and Applied Pharmacology, vol. 245, no. 1, pp. 83–90, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. C. Martínez-Campa, C. Alonso-González, M. D. Mediavilla et al., “Melatonin inhibits both ERα activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium,” Journal of Pineal Research, vol. 40, no. 4, pp. 291–296, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. X. Sun, J. M. Fontaine, I. Bartl, B. Behnam, M. J. Welsh, and R. Benndorf, “Induction of Hsp22 (HspB8) by estrogen and the metalloestrogen cadmium in estrogen receptor-positive breast cancer cells,” Cell Stress and Chaperones, vol. 12, no. 4, pp. 307–319, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Casano, M. Agnello, R. Sirchia, and C. Luparello, “Cadmium effects on p38/MAPK isoforms in MDA-MB231 breast cancer cells,” BioMetals, vol. 23, no. 1, pp. 83–92, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. M. Brama, L. Gnessi, S. Basciani et al., “Cadmium induces mitogenic signaling in breast cancer cell by an ERα-dependent mechanism,” Molecular and Cellular Endocrinology, vol. 264, no. 1-2, pp. 102–108, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. S. Jain, J. A. Coulter, A. R. Hounsell et al., “Cell-Specific Radiosensitization by gold nanoparticles at megavoltage radiation energies,” International Journal of Radiation Oncology Biology Physics, vol. 79, no. 2, pp. 531–539, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. E. S. Day, L. R. Bickford, J. H. Slater, N. S. Riggall, R. A. Drezek, and J. L. West, “Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer,” International Journal of Nanomedicine, vol. 5, no. 1, pp. 445–454, 2010. View at Google Scholar
  35. S. W. Wong, K. H. Tiong, W. Y. Kong et al., “Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73,” Breast Cancer Research and Treatment, vol. 128, no. 2, pp. 301–313, 2011. View at Publisher · View at Google Scholar · View at PubMed
  36. N. Al-Taweel, E. Varghese, and D. Büsselberg, “Cisplatin triggers cell death of MCF-7 cells following disruption of [Ca2+]i homeostasis,” in Proceedings of the 3rd International Symposium on Metallomics, Doha, Qatar, 2011.
  37. F. Splettstoesser, A. M. Florea, and D. Büsselberg, “IP3 receptor antagonist, 2-APB, attenuates cisplatin induced Ca2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis,” British Journal of Pharmacology, vol. 151, no. 8, pp. 1176–1186, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. L. G. O. Brito, J. M. de Andrade, T. Lins-Almeida et al., “Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients,” Medical Oncology. In press. View at Publisher · View at Google Scholar · View at PubMed
  39. L. H. de Lima Araújo, M. V. Moitinho, A. M. F. Silva, C. A. S. Gomes, and H. Noronha Júnior, “Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience,” Medical Oncology. In press. View at Publisher · View at Google Scholar · View at PubMed
  40. L. Xu, S. Yin, S. Banerjee, F. Sarkar, and K. B. Reddy, “Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells,” Molecular Cancer Therapeutics, vol. 10, no. 3, pp. 550–557, 2011. View at Publisher · View at Google Scholar · View at PubMed
  41. R. W. Rowe, F. R. Strebel, J. M. Proett et al., “Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model,” International Journal of Hyperthermia, vol. 26, no. 6, pp. 565–576, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. F. Mendes, M. Groessl, A. A. Nazarov et al., “Metal-based inhibition of poly(ADP-ribose) polymerase-the guardian angel of DNA,” Journal of Medicinal Chemistry, vol. 54, no. 7, pp. 2196–2206, 2011. View at Publisher · View at Google Scholar · View at PubMed
  43. Z. Dvořák, P. Štarha, and Z. Trávníček, “Evaluation of in vitro cytotoxicity of 6-benzylaminopurine carboplatin derivatives against human cancer cell lines and primary human hepatocytes,” Toxicology in Vitro, vol. 25, no. 3, pp. 652–656, 2011. View at Publisher · View at Google Scholar · View at PubMed
  44. A. S. Paraskar, S. Soni, K. T. Chin et al., “Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 28, pp. 12435–12440, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. A. Muscella, N. Calabriso, C. Vetrugno et al., “The platinum (II) complex [Pt(O,O'-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells,” Biochemical Pharmacology, vol. 81, no. 1, pp. 91–103, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. O. I. Alatise and G. N. Schrauzer, “Lead exposure: a contributing cause of the current breast cancer epidemic in Nigerian Women,” Biological Trace Element Research, vol. 136, no. 2, pp. 127–139, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. K. Splith, W. Hu, U. Schatzschneider et al., “Protease-activatable organometal-peptide bioconjugates with enhanced cytotoxicity on cancer cells,” Bioconjugate Chemistry, vol. 21, no. 7, pp. 1288–1296, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. T. Chen and Y. S. Wong, “Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 3, pp. 666–676, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. H. Greenlee, M. D. Gammon, P. E. Abrahamson et al., “Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project,” Cancer, vol. 115, no. 14, pp. 3271–3282, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. S. Suzana, B. G. Cham, G. Ahmad Rohi et al., “Relationship between selenium and breast cancer: a case-control study in the Klang Valley,” Singapore Medical Journal, vol. 50, no. 3, pp. 265–269, 2009. View at Google Scholar · View at Scopus
  51. T. Dziaman, T. Huzarski, D. Gackowski et al., “Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 11, pp. 2923–2928, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. W. C. Hawkes, T. T. Y. Wang, Z. Alkan, B. D. Richter, and K. Dawson, “Selenoprotein W modulates control of cell cycle entry,” Biological Trace Element Research, vol. 131, no. 3, pp. 229–244, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. Z. Li, L. Carrier, A. Belame et al., “Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis,” Breast Cancer Research and Treatment, vol. 118, no. 1, pp. 33–43, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. Z. Li, L. Carrier, and B. G. Rowan, “Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells,” Molecular Cancer Therapeutics, vol. 7, no. 9, pp. 3056–3063, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. S. Li, Y. Zhou, Y. Dong, and C. Ip, “Doxorubicin and selenium cooperatively induce Fas signaling in the absence of Fas/Fas ligand interaction,” Anticancer Research, vol. 27, no. 5 A, pp. 3075–3082, 2007. View at Google Scholar · View at Scopus
  56. S. Li, Y. Zhou, R. Wang, H. Zhang, Y. Dong, and C. Ip, “Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates,” Molecular Cancer Therapeutics, vol. 6, no. 3, pp. 1031–1038, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus